Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Literature
1.
Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, Van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18:169–91.CrossRef
2.
Grandhi R, Alikhan A. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatology. 2017;233(2–3):141–4.CrossRef
3.
Rehman H, Sarwar U, Majeed MM, Bokhari MA. Treatment of post adolescent female acne with spironolactone and low dose Isotretinoin. Med Forum Mon. 2018;29(5):2–6 (ISSN 1029385X).
4.
Charny JW, Choi JK, James WD. Spironolactone for the treatment of acne in women, a retrospective study of 110 patients. Int J Womens Dermatol. 2017;3(2):111–5.CrossRef
5.
Isvy-Joubert A, Nguyen JM, Gaultier A, Saint-Jean M, Le Moigne M, Boisrobert E, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol. 2017;27(4):393–8.CrossRef
6.
Thiede RM, Rastogi S, Nardone B, Sadowsky LM, Rangel SM, West DP, et al. Hyperkalemia in women with acne exposed to oral spironolactone: a retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program. Int J Womens Dermatol. 2019;5(3):155–7.CrossRef
7.
Elshimy N, Whitehouse H, Blakeway E, Eady A, Layton A. Is it necessary to monitor serum electrolytes in healthy women using spironolactone for the treatment of acne? Br J Dermatol. 2017;177:74–5.
8.
Barbieri JS, Choi JK, Mitra N, Margolis DJ. Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010–2016. J Drugs Dermatol. 2018;17(6):632–8.PubMed
9.
Sanai M, Shaukat S, Ghias A, Asghar A, Nadeem M, Ahmed TJ. Efficacy and safety of spironolactone in moderate to severe acne in females. J Pakistan Assoc Dermatol. 2019;29(1):101–9.
Metadata
Title
Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature
Authors
Ruth A. Barker
Christopher Wilcox
Alison M. Layton
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 2/2020
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-020-00511-5

Other articles of this Issue 2/2020

American Journal of Clinical Dermatology 2/2020 Go to the issue

Review Article

Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris

Short Communication

Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail Infections

Review Article

Psoriatic Disease in the US Latino Population: A Comprehensive Review

Systematic Review

Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes

Review Article

Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management

Leading Article

Updates on Botulinum Neurotoxins in Dermatology